Design Mark 99068757

Registered
Design Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

GG

Owner Name

Type: Organization / Private Company Limited by Shares

Address

GSK Medicines Research Centre, Gunnels Wood Road
Stevenage, SG1 2NY
United Kingdom

Critical Dates

First Use Date

Not filed yet

Filing Date

Mar 5, 2025

Registration Date

Jan 13, 2026

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological...

Mark Elements

Text Mark
Design Mark 99068757
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description

The mark consists of a stylized incomplete square formed from a dark blue right scalene triangle along the square's top and left upper corner, a dark blue right scalene triangle along the square's right side and lower right corner, and a larger light blue scalene triangle that extends from below the bottom of the square through the square's top right corner.

Color Details

The color(s) dark blue, and light blue is/are claimed as a feature of the mark.

Design Search Codes
26.05.14
Three triangles
26.05.21
Triangles that are completely or partially shaded
26.09.03
Incomplete squares
26.09.09
Squares made of geometric figures, objects, humans, plants or animals
26.09.21
Squares that are completely or partially shaded
26.09.28
Miscellaneous designs with overall square shape
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

Filing Date

Mar 5, 2025

Publication Date

Nov 25, 2025

Registration Date

Jan 13, 2026

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 11:38 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The mark is a stylized incomplete square design in dark blue and light blue, formed by three scalene triangles, covering pharmaceuticals in International Class 005 for treating damaged skin, pain, inflammation, obesity, infectious diseases, and various disorders including viral, metabolic, and immune-related conditions, plus anti-infectives and vaccines (with additional domestic classes 006, 018, 044, 046, 051, and 052). It is owned by Glaxo Group Limited, a UK private company limited by shares based at GSK Medicines Research Centre in Stevenage, UK. The mark is registered on the Principal Register since January 13, 2026 (Registration No. 8099426), with no notable issues or active legal proceedings.

Recent Activity

Filed on March 5, 2025 (Application No. 99068757) based on UK and Chinese priorities, it faced a non-final office action on August 14, 2025, followed by a response on October 8, 2025. It was approved on October 29, 2025, published for opposition on November 25, 2025, and registered on January 13, 2026.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 11:38 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.